Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for Psychosis Associated With Alzheimer's Disease
Drug: KarXT
147 locations incl. Homewood
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 55 - 90
Code: NCT05980949·Phase 3·Recruiting